T-Cell Engagers — Modern Immune-Based Therapies for Multiple Myeloma

Overview of attention for article published in New England Journal of Medicine, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 34 X users

patent: 10 patents
facebook: 1 Facebook page

Readers on

mendeley: 37 Mendeley

So far, Altmetric has seen 37 X posts from 34 X users, with an upper bound of 1,128,932 followers.

Editorial putting the data in context based on current landscape of treatment options. https://t.co/oZEx8fvuuT

RT @NEJM: New editorial by Sham Mailankody, M.B., B.S., and Ola Landgren, M.D., Ph.D.: "T-Cell Engagers — Modern Immune-Based Therapies for…

RT @DrOlaLandgren: Now online in NEJM: “T-Cell Engagers: Modern Immune-Based Therapies for Multiple Myeloma.” Great for Patients with Mye…

RT @NEJM: New editorial by Sham Mailankody, M.B., B.S., and Ola Landgren, M.D., Ph.D.: "T-Cell Engagers — Modern Immune-Based Therapies for…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 33 additional X posts.